5 Star

”The targets to end AIDS stipulates that 90 per cent of persons living with HIV would know their status by 2020 and 90 per cent of those diagnosed with HIV would receive antiretroviral therapy and 90 per cent of those receiving treatment would be virally suppressed.

Moma-Efretuei said that this imitative would form the bedrock on which future interventions would lie.

The FCT Regional Manager, Institute of Human Virology, Nigeria, Dr Olayemi Olupitan, urged the Nigerian government to intensify efforts and awareness on HIV testing and treatment.

Olupitan added that UNAIDS had reached advanced stage in its trategy to end AIDS epidemic by 2030 in Nigeria

She added that the Institute of Human Virology, Nigeria, was collaborating with the National Assembly and Methodist Church to provide free medical services to the residents of Karimajiji IDPs.

The Chairman, Karimajiji IDP camp, Mohammed Abubarka, called on the Federal Government to support the IDPs to return to their homes.

Abubarka said that the suffering was too much and it would be appreciated if they could go back home.

”We want to go back home, we want to go back to farming and working, there is no place like home, we are not happy here.

”We have no food, hospital or school, we are suffering and we need help, we have been here for over three years,” he said.

. .

Baumhefner said for many patients with breakthrough disease on standard IFNβ-1a, increasing the treatment dosage with twice-weekly therapy may be an acceptable alternative to switching treatments.

June Halper, MSN, MSCN, CMCS CEO, agreed, noting that "it makes a lot of sense for some patients to stay on a drug that has worked for them, and tweak the therapy if there is a breakthrough instead of automatically moving on to another drug," she told MedPage Today.

Baumhefner said a prospective, blinded, randomized trial comparing once-weekly and twice-weekly intramuscular IFNβ-1a may be warranted.